A phase 1b clinical study of NXP800 in patients with ARID1a-mutated ovarian cancer
NXP800 for the treatment of patients with advanced or metastatic cholangiocarcinoma
A phase 1 clinical study of NXP900 in patients with advanced cancers
A phase 1b clinical study of NXP800 in patients with ARID1a-mutated ovarian cancer
NXP800 for the treatment of patients with advanced or metastatic cholangiocarcinoma
A phase 1 clinical study of NXP900 in patients with advanced cancers